Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

New board members

blog new board members graphic

IPC elects new three new board members

The International Psoriasis Council is governed by a volunteer board of directors comprised of the world’s leading experts in psoriasis who provide business expertise to the organization. We are excited to announce that three new key opinion leaders have been elected to join our board.

Meet our newest board members

Dr. Blauvelt is President of Oregon Medical Research Center.
Andrew Blauvelt, MD, MBA
Oregon Medical Research Center
Portland, Oregon, United States
IPC Board Member
Siew Eng Choon Headshot
Siew Eng Choon, MBBS, FRCP
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia
Johor Bahru, Malaysia
IPC Board Member
Catherine Smith
Catherine Smith, MD
St John’s Institute of Dermatology, Guys and St Thomas’s Hospitals
London, England, United Kingdom
IPC Board Member
A complete list of our Board of Directors with their full biographies can be found here.

Categories

Recent Posts

IPC Welcomes New Councilors Dr. Steven Fakharzadeh and Dr. Rodrigo Garcia Salinas

A New Genetic Clue in Psoriasis: What the ADAR1 Discovery Means

Skin-Derived Myeloid Precursors and Joint-Resident Fibroblasts Spread Psoriatic Disease from Skin to Joints

Also Read

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026